Zimmer Biomet Holdings (ZBH) Non-Current Assets (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Non-Current Assets came in at $17.8 billion in Q1 2026, up 1079.76% year-on-year from $1.5 billion in Q1 2025, and down 1.18% quarter-over-quarter from $18.0 billion in Q4 2025.
Zimmer Biomet Holdings (ZBH) Non-Current Assets (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Non-Current Assets history runs 18 years deep, the most recent figure standing at $17.8 billion for Q1 2026.
- On a quarterly basis, Non-Current Assets rose 1079.76% year-over-year to $17.8 billion in Q1 2026; TTM through Mar 2026 was $33.0 billion, a 6.53% increase from a year earlier, with the FY2025 full-year figure at $18.0 billion, up 1980.88% from the prior year.
- Non-Current Assets retreated to $17.8 billion in Q1 2026 per ZBH's latest filing, from $18.0 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $18.0 billion in Q4 2025 and bottomed at -$1.8 billion in Q1 2025.
- The 5-year median for Non-Current Assets is $16.8 billion (2023), against an average of $11.7 billion.
- Biggest YoY gain for Non-Current Assets was 1980.88% in 2025; the steepest drop was 110.78% in 2025.
- Year by year, Non-Current Assets stood at -$898.6 million in 2022, then jumped by 1979.3% to $16.9 billion in 2023, then slumped by 105.66% to -$955.5 million in 2024, then jumped by 1980.88% to $18.0 billion in 2025, then retreated by 1.18% to $17.8 billion in 2026.
- Per Business Quant, the three latest ZBH Non-Current Assets figures stand at $17.8 billion (Q1 2026), $18.0 billion (Q4 2025), and -$1.8 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2.30 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 26.70 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 6.35 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 20.47 Bn |
| 10 | Zimmer Biomet Holdings | 17.99 Bn | 17.57 Bn | 1.51 Bn | 17.76 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.76 Bn |
| Dec 31, 2025 | 17.97 Bn |
| Sep 30, 2025 | -1.75 Bn |
| Jun 30, 2025 | -988.40 Mn |
| Mar 31, 2025 | -1.81 Bn |
| Dec 31, 2024 | -955.50 Mn |
| Sep 30, 2024 | 16.86 Bn |
| Jun 30, 2024 | 16.88 Bn |
| Mar 31, 2024 | 16.82 Bn |
| Dec 31, 2023 | 16.89 Bn |
| Sep 30, 2023 | 16.85 Bn |
| Jun 30, 2023 | 16.91 Bn |
| Mar 31, 2023 | 16.83 Bn |
| Dec 31, 2022 | -898.60 Mn |
| Sep 30, 2022 | 16.80 Bn |
| Jun 30, 2022 | 16.99 Bn |
| Mar 31, 2022 | 17.10 Bn |
| Dec 31, 2021 | 18.57 Bn |
| Sep 30, 2021 | 18.70 Bn |
| Jun 30, 2021 | 18.87 Bn |